Greenrose Acquisition Corp.
OTC: GNRSW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Nicole Conboy
- Employees
- 91
- Headquarters
- United States
- IPO year
- 2020
- Market cap
- $1.8K
Loading GNRSW…
Loading profile data…Frequently asked questions about GNRSW
What does Greenrose Acquisition Corp. (GNRSW) do?
Greenrose Holding Company Inc., operating via its subsidiaries, specializes in the manufacturing and commercialization of cannabis products. Its core business functions include cultivating, processing, and packaging medicinal cannabis and its related derivative items. The organization was established in 2014 and maintains its corporate headquart...
Where does GNRSW trade?
Greenrose Acquisition Corp. (GNRSW) trades on the Other OTC.
What sector is GNRSW in?
Greenrose Acquisition Corp. (GNRSW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Greenrose Acquisition Corp.?
Nicole Conboy is the chief executive officer of Greenrose Acquisition Corp. (GNRSW).
Where is Greenrose Acquisition Corp. headquartered?
Greenrose Acquisition Corp. is headquartered in United States.
Does GNRSW pay a dividend?
Greenrose Acquisition Corp. (GNRSW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GNRSW go public?
Greenrose Acquisition Corp. (GNRSW) completed its initial public offering in 2020.